Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Pharmacology, Biochemistry, and Behavior|April 22, 2004
A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug usersWallace B Pickworth, Eun M Lee, Mary E Abreu, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 18, 2015
Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking CessationKelly E Dunn, Taylor F Marcus, Cynthia Kim, et al.
JAMA Network Open|March 15, 2023
Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical TrialOrrin D Ware, Mary M Sweeney, Colin Cunningham, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 12, 2003
Methadone treatment induces attenuation of cerebrovascular deficits associated with the prolonged abuse of cocaine and heroinRonald I Herning, Warren E Better, Kimberly Tate, et al.
Drug and Alcohol Dependence|December 23, 2008
Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingencyDavid H Epstein, John Schmittner, Annie Umbricht, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|November 4, 2014
Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependenceOlga Rass, Annie Umbricht, George E Bigelow, et al.
Drug and Alcohol Dependence|March 14, 2003
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infectionAnnie Umbricht, Donald R Hoover, Marvin J Tucker, et al.
Drug and Alcohol Dependence|July 26, 2011
Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trialAnthony DeFulio, Jeffrey J Everly, Jeannie-Marie S Leoutsakos, et al.
The American Journal on Addictions|April 6, 2022
Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care settingMary M Sweeney, Laura Prichett, Michael I Fingerhood, et al.
Journal of Opioid Management|December 19, 2019
Increases in body mass index and cardiovascular risk factors during methadone maintenance treatmentMary M Sweeney, Denis G Antoine, Leticia Nanda, et al.
Pageof 4